PR Newswire - I-MAB Filed 2023 Annual Report on Form 20-F...
ROCKVILLE, Md., April 30, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of hig...
Read More